Use of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors in Incident Hyponatremia in Patients with Type 2 Diabetes: Multicenter Target Trial Emulations
Clinical pharmacology and therapeutics · 2026 Oct 26 · Lin YH, Tsai DH, Hsieh MH et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 25 20:00 ETSource: Clinical pharmacology and therapeutics
From the source
Read at pubmed.ncbi.nlm.nih.govUse of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors in Incident Hyponatremia in Patients with Type 2 Diabetes: Multicenter Target Trial Emulations
Clinical pharmacology and therapeutics · 2026 Oct 26 · Lin YH, Tsai DH, Hsieh MH et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42935015/
